1. Home
  2. PYPD vs PT Comparison

PYPD vs PT Comparison

Compare PYPD & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • PT
  • Stock Information
  • Founded
  • PYPD 2008
  • PT 2012
  • Country
  • PYPD Israel
  • PT China
  • Employees
  • PYPD N/A
  • PT N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • PT Computer Software: Programming Data Processing
  • Sector
  • PYPD Health Care
  • PT Technology
  • Exchange
  • PYPD Nasdaq
  • PT Nasdaq
  • Market Cap
  • PYPD 35.3M
  • PT 15.2M
  • IPO Year
  • PYPD 2020
  • PT 2018
  • Fundamental
  • Price
  • PYPD $3.59
  • PT $0.89
  • Analyst Decision
  • PYPD Strong Buy
  • PT
  • Analyst Count
  • PYPD 5
  • PT 0
  • Target Price
  • PYPD $11.40
  • PT N/A
  • AVG Volume (30 Days)
  • PYPD 1.4M
  • PT 14.7K
  • Earning Date
  • PYPD 08-13-2025
  • PT 07-07-2025
  • Dividend Yield
  • PYPD N/A
  • PT N/A
  • EPS Growth
  • PYPD N/A
  • PT N/A
  • EPS
  • PYPD N/A
  • PT N/A
  • Revenue
  • PYPD N/A
  • PT $4,814,566.00
  • Revenue This Year
  • PYPD N/A
  • PT N/A
  • Revenue Next Year
  • PYPD N/A
  • PT N/A
  • P/E Ratio
  • PYPD N/A
  • PT N/A
  • Revenue Growth
  • PYPD N/A
  • PT N/A
  • 52 Week Low
  • PYPD $2.30
  • PT $0.76
  • 52 Week High
  • PYPD $4.49
  • PT $1.15
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 59.00
  • PT 46.18
  • Support Level
  • PYPD $3.12
  • PT $0.82
  • Resistance Level
  • PYPD $3.75
  • PT $0.94
  • Average True Range (ATR)
  • PYPD 0.29
  • PT 0.06
  • MACD
  • PYPD 0.01
  • PT 0.00
  • Stochastic Oscillator
  • PYPD 69.83
  • PT 57.14

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: